InvestSMART

Micro-X Limited (ASX:MX1)

ALERT: Price-sensitive ASX Announcement for MX1
Current share price for MX1 : $0.029 -0.025 (-46.30%)+
Announcement
Release
30 Apr 2026 12:45PM
Price at Release
$0.054
Full Release
download
Summary
The Quarterly Activities Report and Appendix 4C from Micro-X Limited for the quarter ended 31 March 2026 highlights significant developments and financial results. The company has seen market interest in its Rover 2026 model, which debuted at the RSNA conference. Operationally, the first Head CT test bench was installed at the Royal Melbourne Hospital, marking progress in their imaging capabilities. Financially, Micro-X received $0.9 million from product sales and completed a placement resulting in $1.6 million received, with a cash balance of $3.5 million at the quarter's end. The company is preparing for further commercialization efforts, particularly in its Head CT imaging program, and has ongoing discussions regarding monetizing its security applications. The financial report indicates a net cash outflow from operations of $2.7 million and outlines expectations for upcoming tax incentives and consulting receipts.
Key Points
  • Rover 2026 model gaining traction post RSNA conference.
  • Installation of first Head CT test bench at Royal Melbourne Hospital.
  • Received $0.9 million in customer receipts from product sales.
  • Closed a $1.6 million placement in December 2025.
  • Cash balance of $3.5 million at 31 March 2026.
  • Discussions ongoing for monetization of security applications.
  • Net cash outflow from operations was $2.7 million.
  • Anticipated $5 million R&D Tax Incentive Rebate.
  • $10 million in contracted consulting receipts expected.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.